Sana Al Sukhun

Aug 13, 2024 | digitalcommons.library.tmc.edu | Sana Al Sukhun |Bogda Koczwara |Sarah Temin |Banu Arun

To view the content in your browser, please download Adobe Reader or, alternately, you may Download the file to your hard drive. NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.

Jan 10, 2024 | brnw.ch | Sana Al Sukhun |Sarah Temin |Carlos H. Barrios

SPECIAL ARTICLES IntroductionThe purpose of this guideline is to provide expert guidance on the systemic treatment of metastatic breast cancer (MBC) to clinicians, public health leaders, patients, and policymakers in resource-constrained settings. This guideline's target population is adult patients with MBC in resource-constrained settings, and it focuses on medical treatment. This guideline is not intended for patients in Maximal settings, as described in Table 1.

Jan 10, 2024 | brnw.ch | Sana Al Sukhun |Sarah Temin

SPECIAL ARTICLES In 2024, ASCO published a guideline for clinicians, patients, and policymakers in resource-constrained settings on the treatment of patients with metastatic breast cancer (MBC).1 The purpose of that guideline is to provide expert guidance on the systemic treatment of MBC to clinicians, public health leaders, patients, and policymakers in resource-constrained settings (Appendix Table A1).